EAP-DERIVED MONOCLONAL ANTIBODIES FOR PHENOTYPING GUINEA PIG IMMUNE CELLS.
EAP-DERIVED MONOCLONAL ANTIBODIES FOR PHENOTYPING GUINEA PIG IMMUNE CELLS.
批准号:
10291475
负责人:
MARK GEISBERG
金额:
$60.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2022-06-30
关键词:
AddressAffinityAntibodiesAntibody SpecificityAntigen TargetingAntigensBindingBioinformaticsBiological AssayCaviaCellsDiseaseEbolaEpitopesGoalsHybridomasImmuneImmune SeraImmunizationInfluenzaModelingMonoclonal AntibodiesMusPeptidesPeripheral Blood Mononuclear CellPhenotypePreparationProductionReagentResearchSurface AntigensTissuesTuberculosisValidationZIKV infectioncandidate validationcytokinenew technologynovelscreening
中文摘要
该建议解决了新型单抗(MAbs)在豚鼠模型中表征免疫细胞亚群和细胞因子的需要。他们的目标是利用他们的新技术来制备针对六种靶抗原的高亲和力单抗,重点放在免疫细胞的表面标记上,并用豚鼠PBMCs和组织切片来表征抗体的特异性。这些新试剂将可用于显著增强结核病和其他疾病(如流感、埃博拉和寨卡病毒感染)的研究能力。
英文摘要
The proposal addressed the need for novel monoclonal Abs (MAbs) to characterize subsets of immune cells and cytokines in the guinea pig model. The goal is to use their novel technology to produce high-affinity MAbs against six target antigens, focusing on surface markers of immune cells, and to characterize the specificity of antibodies with guinea pig PBMCs and tissue section. These new reagents will be available to significantly enhance research capabilities for tuberculosis and other diseases such as influenza, Ebola and Zika viral infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EAP-Derived Monoclonal Antibodies for Phenotyping Immune Cells of Animal Model of Disease
-
批准号:10933282
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2023
-
负责人:MARK GEISBERG
-
依托单位:
A Rapid and Inexpensive Point-of-Care Test for Beta-Thalassemia Carriers
-
批准号:10053692
-
项目类别:
-
资助金额:$34.85万
-
财政年份:2020
-
负责人:MARK GEISBERG
-
依托单位:
Development of Faster, Lower-Cost, High-Sensitivity Immunoassay for Specific Determination of Glucagon Using EAP-derived Monoclonal Antibodies
-
批准号:9107441
-
项目类别:
-
资助金额:$22.01万
-
财政年份:2015
-
负责人:MARK GEISBERG
-
依托单位:
Rapid LFIA blood test for SCD using highly specific monoclonal antibodies
-
批准号:9170967
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2014
-
负责人:MARK GEISBERG
-
依托单位:
Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens
-
批准号:8699863
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2014
-
负责人:MARK GEISBERG
-
依托单位:
Rapid LFIA blood test for SCD using highly specific monoclonal antibodies
-
批准号:8902261
-
项目类别:
-
资助金额:$22.15万
-
财政年份:2014
-
负责人:MARK GEISBERG
-
依托单位:
Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens
-
批准号:9199051
-
项目类别:
-
资助金额:$99.46万
-
财政年份:2014
-
负责人:MARK GEISBERG
-
依托单位:
Rapid LFIA blood test for SCD using highly specific monoclonal antibodies
-
批准号:9335966
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2014
-
负责人:MARK GEISBERG
-
依托单位:
Rapid Point-of-Care Test Kit for the Detection of Bacteriuria Calibrated for Imme
-
批准号:7800833
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2010
-
负责人:MARK GEISBERG
-
依托单位:
Rapid Point-of-Care Test to Detect Bacteriuria & Confirm Urinary Tract Infection
-
批准号:8293081
-
项目类别:
-
资助金额:$50.77万
-
财政年份:2010
-
负责人:MARK GEISBERG
-
依托单位:
Rapid Point-of-Care Test to Detect Bacteriuria & Confirm Urinary Tract Infection
-
批准号:8198345
-
项目类别:
-
资助金额:$49.23万
-
财政年份:2010
-
负责人:MARK GEISBERG
-
依托单位:
海外基金